Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
371.45
-2.5 (-0.67%)
BSENSE

Jun 18

BSE+NSE Vol: 56.03 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Innova Captab
IOL Chemicals
Bliss GVS Pharma
Advanced Enzyme
RPG LifeScience.
Gufic BioScience
SMS Pharma.
Aarti Drugs
Guj. Themis Bio.
Orchid Pharma
Zota Health Care
Why is Advanced Enzyme Technologies Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Poor long term growth as Operating profit has grown by an annual rate -1.41% of over the last 5 years
3
Positive results in Mar 26
  • PAT(Q) At Rs 42.88 cr has Grown at 61.9%
  • NET SALES(Q) Highest at Rs 203.37 cr
  • PBDIT(Q) Highest at Rs 63.23 cr.
4
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 20-May-26 and has generated -4.31% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
5
With ROE of 9.8, it has a Very Expensive valuation with a 2.6 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 10.47%, its profits have risen by 22.3% ; the PEG ratio of the company is 1.2
6
High Institutional Holdings at 30.9%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Advanced Enzyme should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Advanced Enzyme for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Advanced Enzyme
10.47%
0.27
39.06%
Sensex
-5.16%
-0.39
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.24%
EBIT Growth (5y)
-1.41%
EBIT to Interest (avg)
63.44
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0.46
Tax Ratio
25.34%
Dividend Payout Ratio
44.37%
Pledged Shares
0
Institutional Holding
30.90%
ROCE (avg)
19.58%
ROE (avg)
9.95%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
42
Price to Book Value
2.56
EV to EBIT
18.55
EV to EBITDA
15.30
EV to Capital Employed
3.64
EV to Sales
4.70
PEG Ratio
1.17
Dividend Yield
0.32%
ROCE (Latest)
19.60%
ROE (Latest)
9.82%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
PAT(Q)

At Rs 42.88 cr has Grown at 61.9%

NET SALES(Q)

Highest at Rs 203.37 cr

PBDIT(Q)

Highest at Rs 63.23 cr.

PBT LESS OI(Q)

Highest at Rs 52.46 cr.

-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 5.14 times

Loading Valuation Snapshot...
Here's what is working for Advanced Enzyme
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 52.46 cr has Grown at 51.14%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 42.88 cr has Grown at 61.9%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 203.37 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 203.37 cr has Grown at 21.65%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 63.23 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 52.46 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Advanced Enzyme
Debtors Turnover Ratio- Half Yearly
Lowest at 5.14 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio